Middle East News Dispatch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Dispatch.

Press releases published on April 20, 2026

Apr. 20, 2026

Avicanna Announces Agenda for 6th Annual Clinical Symposium on Cannabinoid Therapeutics

Indeterminate GlobeNewswire

Apr. 20, 2026

Allogene Therapeutics Showcases Momentum with Clinical and Platform Advancements in Allogeneic CAR T at AACR 2026

Indeterminate GlobeNewswire

Apr. 20, 2026

Tanbreez Mining Greenland A/S Appoints Thomas “TYT” Mogensen as Chief Executive Officer

Indeterminate GlobeNewswire

Apr. 20, 2026

Nayax at the NAMA Show 2026: Turning Payment Complexity into a Competitive Edge

Indeterminate GlobeNewswire

Apr. 20, 2026

Nanox Signs Commercial Agreement with Howard Technology Solutions to Deploy 300 Nanox.ARC Systems Across U.S. Over Three Years

Indeterminate GlobeNewswire

Apr. 20, 2026

Foresight Enters Non-Binding Term Sheet for $17.5 Million Strategic Investment at Significant Premium to Current Market Price and Focus on Defense Collaboration

Indeterminate GlobeNewswire

Apr. 20, 2026

Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY®

Indeterminate GlobeNewswire

Apr. 20, 2026

Fulcrum Therapeutics to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, April 27, 2026, at 8:00 a.m. ET

Indeterminate GlobeNewswire

Apr. 20, 2026

Global Uranium Completes Phase 1 Earn-In at Astro Project and Secures Initial 20% Interest

Indeterminate GlobeNewswire

Apr. 20, 2026

COSCIENS Biopharma Inc. Provides Update on its Plan to Suspend U.S. Public Company Reporting Obligations

Indeterminate GlobeNewswire

Apr. 20, 2026

Atsena Therapeutics Receives Data Monitoring Committee Recommendation to Proceed with Pivotal Part C Cohort of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis

Indeterminate GlobeNewswire

Apr. 20, 2026

Kyverna Presents Longer-Term Phase 2 Data for Miv-cel in Generalized Myasthenia Gravis at AAN, Demonstrating Deep, Durable Responses through 52 Weeks

Indeterminate GlobeNewswire

Apr. 20, 2026

Tenvie Therapeutics Announces Dosing of First Subject in Phase 1 Clinical Trial of TNV108, an Allosteric SARM1 inhibitor

Indeterminate GlobeNewswire

Apr. 20, 2026

BVI gibt bekannt, dass Virtuoso®, eine neue chirurgische Plattform mit Doppelfunktion, die CE-Kennzeichnung gemäß EU-MDR erhalten hat

Indeterminate GlobeNewswire

Apr. 20, 2026

BVI annonce l’obtention du marquage CE au titre du Règlement européen sur les dispositifs médicaux pour Virtuoso®, une toute nouvelle plateforme chirurgicale à double fonction

Indeterminate GlobeNewswire

Apr. 20, 2026

Enlight to Report First Quarter 2026 Financial Results on Tuesday, May 5, 2026

Indeterminate GlobeNewswire

Apr. 20, 2026

Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer

Indeterminate GlobeNewswire

Apr. 20, 2026

Kornit Digital Expands Digital Production into Footwear and Technical Textiles with Presto MAX PLUS

Indeterminate GlobeNewswire

Apr. 20, 2026

Nanox Announces Fourth Quarter of 2025 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

Apr. 20, 2026

VVC Grants Options

Indeterminate GlobeNewswire